Western Regional Blog – BC, YK, AB, NWT and Nunavut
Recently, there was the first international AACR conference on ovarian cancer. The theme for this meeting was based on OVCARE’s discovery that ovarian cancer is not a single disease.
In the 10 years since the founding of OVCARE, British Columbia’s multidisciplinary ovarian cancer research team, the reputation of our community has transformed from that of a Vancouver-based group of researchers, making individual contributions, to an internationally recognized team reshaping globally the way ovarian cancers are thought of in the research laboratory and in the clinic.
Last week, the American Association of Cancer Research (AACR) hosted the 1st international conference on ovarian cancer and ovarian cancer researchers from around the globe attended this 4-day event. OVCARE’s Director and co-Founder, Dr. David Huntsman, co-chaired the meeting which also featured Dr. Sohrab Shah, OVCARE’s bioinformatics leader, as an invited speaker. The overall theme of the meeting was that subtype specific treatments will be needed if we are to improve outcomes for patients with ovarian cancer. This idea stems from the discovery by OVCARE in 2008 that ovarian cancer is not a single disease but is comprised of multiple, distinct subtypes.
Now, as evidenced by the speakers and posters presented at the meeting, researchers around the world are now adopting this approach to studying ovarian cancer and for development of better management strategies for this disease. Dr. Huntsman is now working with the planning committee to build on the success of this year’s “drug development in ovarian cancer” theme to bring “ovarian cancer prevention” at the forefront for future AACR ovarian cancer meetings.
In 2010, OVCARE launched the world’s first population based ovarian cancer prevention initiative based on the discovery that most ovarian cancers develop in the fallopian tube and not the ovary itself. OVCARE researchers hope that through their efforts and collaboration with other researchers new knowledge from the study of their population-based ovarian cancer prevention program will be available for sharing with the ovarian cancer clinical and research communities.